PLN 7.45
(-0.67%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 75 Thousand PLN | -3739.26% |
2022 | 135 Thousand PLN | -36.92% |
2021 | 214 Thousand PLN | -14.4% |
2020 | 250 Thousand PLN | 84.87% |
2019 | 135.23 Thousand PLN | 709.29% |
2018 | -22.19 Thousand PLN | -109.74% |
2017 | 227.98 Thousand PLN | 34.43% |
2016 | 169.59 Thousand PLN | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -1.17 Million PLN | 102.35% |
2024 Q1 | -1.19 Million PLN | -34.8% |
2023 Q1 | 39 Thousand PLN | 129.41% |
2023 FY | -4.91 Million PLN | -3739.26% |
2023 Q4 | -885 Thousand PLN | -3260.71% |
2023 Q3 | 28 Thousand PLN | 250.0% |
2023 Q2 | 8000.00 PLN | -79.49% |
2022 Q1 | 51 Thousand PLN | -60.16% |
2022 FY | 135 Thousand PLN | -36.92% |
2022 Q4 | 17 Thousand PLN | -48.48% |
2022 Q3 | 33 Thousand PLN | -2.94% |
2022 Q2 | 34 Thousand PLN | -33.33% |
2021 Q4 | 128 Thousand PLN | 88.24% |
2021 Q2 | -30 Thousand PLN | -162.5% |
2021 Q1 | 48 Thousand PLN | -96.35% |
2021 Q3 | 68 Thousand PLN | 326.67% |
2021 FY | 214 Thousand PLN | -14.4% |
2020 Q4 | 1.31 Million PLN | 377.19% |
2020 Q1 | -436.31 Thousand PLN | -628.86% |
2020 Q2 | -154.21 Thousand PLN | 64.66% |
2020 Q3 | -474.37 Thousand PLN | -207.61% |
2020 FY | 250 Thousand PLN | 84.87% |
2019 Q2 | -70.61 Thousand PLN | -166.8% |
2019 FY | 135.23 Thousand PLN | 709.29% |
2019 Q4 | 82.5 Thousand PLN | 367.83% |
2019 Q3 | 17.63 Thousand PLN | 124.97% |
2019 Q1 | 105.71 Thousand PLN | 939.95% |
2018 Q1 | 4343.93 PLN | -97.5% |
2018 Q4 | -12.58 Thousand PLN | -94.3% |
2018 Q2 | -8587.02 PLN | -297.68% |
2018 FY | -22.19 Thousand PLN | -109.74% |
2018 Q3 | -6477.26 PLN | 24.57% |
2017 Q2 | 17.93 Thousand PLN | 0.0% |
2017 FY | 227.98 Thousand PLN | 34.43% |
2017 Q3 | 18.29 Thousand PLN | 2.0% |
2017 Q4 | 174 Thousand PLN | 851.07% |
2016 FY | 169.59 Thousand PLN | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Adiuvo Investments S.A. | 983 Thousand PLN | 92.37% |
Genomtec S.A. | -793 Thousand PLN | 109.458% |
Medicalgorithmics S.A. | 35.86 Million PLN | 99.791% |
Synektik Spólka Akcyjna | 190.86 Million PLN | 99.961% |